Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
作者信息
Ingraham Nicholas E, Boulware David, Sparks Matthew A, Schacker Timothy, Benson Bradley, Sparks Jeffrey A, Murray Thomas, Connett John, Chipman Jeffrey G, Charles Anthony, Tignanelli Christopher J
机构信息
Division of Pulmonary and Critical Care, Department of Medicine, University of Minnesota, MMC 195, 420 Delaware St SE, Minneapolis, MN, 55455, USA.
Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, USA.
出版信息
Crit Care. 2020 Apr 28;24(1):182. doi: 10.1186/s13054-020-02894-7.
Abstract
摘要
相似文献
1
Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.揭示羟氯喹在新型冠状病毒肺炎中的证据
Crit Care. 2020 Apr 28;24(1):182. doi: 10.1186/s13054-020-02894-7.
2
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.抗2019冠状病毒病（COVID-19）的氨基喹啉：氯喹或羟氯喹。
Int J Antimicrob Agents. 2020 Apr;55(4):105945. doi: 10.1016/j.ijantimicag.2020.105945. Epub 2020 Mar 17.
3
Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.氯喹和羟氯喹在2019冠状病毒病中的应用：资源匮乏地区面临的挑战及谨慎使用的必要性
J Coll Physicians Surg Pak. 2020 Jun;30(6):78. doi: 10.29271/jcpsp.2020.Supp1.S78.
4
Chloroquine and hydroxychloroquine in covid-19.氯喹和羟氯喹在2019冠状病毒病中的应用
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
5
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.氯喹和羟氯喹用于治疗新型冠状病毒肺炎的安全性考量
Clin Microbiol Infect. 2020 Sep;26(9):1276-1277. doi: 10.1016/j.cmi.2020.05.006. Epub 2020 May 16.
6
Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.氯喹和羟氯喹毒性及处理的简要综述。
West J Emerg Med. 2020 Jun 3;21(4):760-763. doi: 10.5811/westjem.2020.5.47810.
7
The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.羟氯喹与 COVID-19 ：一个警示故事。
Ann Intern Med. 2020 Oct 20;173(8):662-663. doi: 10.7326/M20-5041. Epub 2020 Jul 16.
8
Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.羟氯喹治疗新型冠状病毒肺炎：在等待确凿科学证据期间如何使用
Med Clin (Barc). 2020 Aug 14;155(3):134-135. doi: 10.1016/j.medcli.2020.05.006. Epub 2020 May 16.
9
Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.用于治疗冠状病毒的羟氯喹：迫切需要暂停处方使用
Am J Med. 2020 Sep;133(9):1007-1008. doi: 10.1016/j.amjmed.2020.05.005. Epub 2020 Jun 2.
10
Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients.新出现的临床前证据不支持在新冠肺炎患者中广泛使用羟氯喹。
Nat Commun. 2020 Aug 26;11(1):4253. doi: 10.1038/s41467-020-17907-w.
引用本文的文献
1
Racial and Ethnic Disparities in Hospital Admissions from COVID-19: Determining the Impact of Neighborhood Deprivation and Primary Language.COVID-19 住院患者中的种族和民族差异：确定邻里剥夺和主要语言的影响。
J Gen Intern Med. 2021 Nov;36(11):3462-3470. doi: 10.1007/s11606-021-06790-w. Epub 2021 May 18.
2
COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases.COVID-19、羟氯喹和心脏性猝死：对风湿性疾病患者临床实践的影响。
Rheumatol Int. 2021 Feb;41(2):257-273. doi: 10.1007/s00296-020-04759-2. Epub 2021 Jan 1.
3
Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?回复 Gautret 等人：硫酸羟氯喹和阿奇霉素治疗 COVID-19：有何证据，有何风险？
Int J Antimicrob Agents. 2020 Jul;56(1):106056. doi: 10.1016/j.ijantimicag.2020.106056. Epub 2020 Jul 13.
4
A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics.关于新型冠状病毒肺炎（严重急性呼吸综合征冠状病毒2）治疗方法现代进展的观点。
Eur J Rheumatol. 2020 Aug;7(Suppl 2):S102-S106. doi: 10.5152/eurjrheum.2020.2065. Epub 2020 May 22.
本文引用的文献
1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
2
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒（2019 - 新冠病毒）。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
3
Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.评估免疫调节剂、干扰素及已知的体外严重急性呼吸综合征冠状病毒（SARS-CoV）抑制剂对BALB/c小鼠体内SARS-CoV复制的抑制作用。
Antivir Chem Chemother. 2006;17(5):275-84. doi: 10.1177/095632020601700505.
4
Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities.具有抗疟和抗病毒活性的羟基铁喹衍生物的设计与合成。
J Med Chem. 2006 May 4;49(9):2845-9. doi: 10.1021/jm0601856.
5
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.氯喹是一种有效的严重急性呼吸综合征冠状病毒感染和传播抑制剂。
Virol J. 2005 Aug 22;2:69. doi: 10.1186/1743-422X-2-69.
Zotero 插件